News & Analysis on Clinical Trial Services & Contract Research And Development
Acclinate Genetics launches e-DICT, a clinical trials management system aiming to close the gap between the population rate of minorities in the US and their participation rate in clinical trials.
Sartorius Stedim to offer the GMP manufacture of mammalian cell banks for the biopharmaceutical industry alongside characterization services.
Eversana looks to enhance its service in Asia and meet ‘increased’ demand with new offices in Singapore, Mumbai, Shanghai, and Tokyo.
Through the combined offerings of WCG and PharmaSeek, the companies will be able to make a clinical trial site’s success both ‘predictable and achievable,’ says CEO.
Prellis advances its goal of using 3D holographic printing to create organoids for research and development – recently closing a $10.5m investment round to further develop its technology, which accelerates drug screening, says CEO.
US FDA issues another Form 483 with six observations to Natco Pharma, noting procedural discrepancies.
Courts continue to rule in favor of Lilly’s lung cancer treatment patent, as the District Court for Appeals concludes generic producers like Dr Reddy’s to be potentially infringing.
The provider research models and services, BioIVT, has acquired Hatboro-PA-based Keystone Biologicals, which supplies disease-state plasma, sera, and controls.